Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
8.30
-0.04 (-0.54%)
Oct 21, 2025, 2:50 PM EDT - Market open

Gyre Therapeutics Revenue

Gyre Therapeutics had revenue of $26.77M in the quarter ending June 30, 2025, with 6.13% growth. This brings the company's revenue in the last twelve months to $102.19M, down -8.42% year-over-year. In the year 2024, Gyre Therapeutics had annual revenue of $105.76M, down -6.78%.

Revenue (ttm)
$102.19M
Revenue Growth
-8.42%
P/S Ratio
7.06
Revenue / Employee
$176,492
Employees
579
Market Cap
753.41M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024105.76M-7.69M-6.78%
Dec 31, 2023113.45M11.16M10.91%
Dec 31, 2022102.29M--